Literature DB >> 18617784

Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease.

Harry R Dalton1, William Stableforth, Prem Thurairajah, Simon Hazeldine, Rene Remnarace, Warshow Usama, Liz Farrington, Noor Hamad, Cyril Sieberhagen, Vic Ellis, Jonathan Mitchell, S Hyder Hussaini, Malcolm Banks, Samreen Ijaz, Richard P Bendall.   

Abstract

AIMS: To report the natural history of autochthonous hepatitis E and hepatitis E virus (HEV) IgG seroprevalence in Southwest England.
METHODS: Patients with unexplained hepatitis were tested for hepatitis E and cases followed until recovery or death. Five hundred blood donors, 336 individuals over the age of 60 years and 126 patients with chronic liver disease were tested for HEV IgG.
RESULTS: Forty cases of autochthonous hepatitis E (genotype 3) were identified. Hepatitis E was anicteric in 25% of cases and usually caused a self-limiting hepatitis predominantly in elderly Caucasian males. Six of 40 had a significant complication and three patients died, two of who had previously undiagnosed cirrhosis. Hepatitis E shows a seasonal variation with peaks in the spring and summer and no cases in November and December. HEV IgG prevalence increases with age, is more common in men and is 16% in blood donors, 13% in patients with chronic liver disease and 25% in individuals over 60 years.
CONCLUSION: Autochthonous hepatitis E is more common than previously recognized, and should be considered in the differential diagnosis in patients with hepatitis, whatever their age or travel history. It carries a significant morbidity and when seen in the context of chronic liver disease carries an adverse prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617784     DOI: 10.1097/MEG.0b013e3282f5195a

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  84 in total

1.  Clopidogrel, Turkey and a red herring?

Authors:  S P Leighton; C Gordon; A Shand
Journal:  BMJ Case Rep       Date:  2011-04-09

2.  Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana-Belén Blázquez; María Lorenzo; Miguel A Martín-Acebes; Rafael Blasco; Juan-Carlos Saiz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Hepatitis E virus infection in a patient with suspected drug-induced liver injury.

Authors:  Ashfaque Memon; Jose Miranda
Journal:  BMJ Case Rep       Date:  2017-01-31

4.  Hepatobiliary quiz-8 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-12

Review 5.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

6.  Hepatitis E Seroprevalence and Genotyping in a Cohort of Wild Boars in Southern Germany and Eastern Alsace.

Authors:  Kilian Weigand; Kurt Weigand; Mathias Schemmerer; Martina Müller; Juergen J Wenzel
Journal:  Food Environ Virol       Date:  2017-12-06       Impact factor: 2.778

7.  Hepatitis e virus: current concepts and future perspectives.

Authors:  Harry R Dalton; Suzan D Pas; Richie G Madden; Annemiek A van der Eijk
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

8.  Seasonal pattern of hepatitis E virus prevalence in swine in two different geographical areas of China.

Authors:  Y H Lu; H Z Qian; A Q Hu; X Qin; Q W Jiang; Y J Zheng
Journal:  Epidemiol Infect       Date:  2013-02-06       Impact factor: 2.451

Review 9.  Chronic hepatitis E: A brief review.

Authors:  Arvind R Murali; Vikram Kotwal; Saurabh Chawla
Journal:  World J Hepatol       Date:  2015-09-08

Review 10.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.